Pfizer (PFE) P/S (1999 - 2026)
Pfizer (PFE) P/S from Nov 1, 1999 to Jul 20, 2026. The TTM Pfizer (PFE) P/S is 2.22. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/S
Annual P/S change of Pfizer (PFE)
| Year | P/S | Change |
|---|---|---|
| 2026 | 2.22 | -1.65% |
| 2025 | 2.26 | -4.27% |
| 2024 | 2.36 | -11.71% |
| 2023 | 2.68 | -14.09% |
| 2022 | 3.12 | -30.74% |
| 2021 | 4.50 | -8.41% |
| 2020 | 4.91 | -2.54% |
| 2019 | 5.04 | -15.45% |
| 2018 | 5.96 | +129.90% |
| 2017 | 2.59 | -132.63% |
| 2015 | -7.94 | -258.84% |
| 2014 | 5.00 | +34.89% |
| 2013 | 3.71 | +14.53% |
| 2012 | 3.24 | +33.03% |
| 2011 | 2.43 | +18.91% |
| 2010 | 2.05 | -21.86% |
| 2009 | 2.62 | +77.72% |
| 2008 | 1.47 | -23.98% |
| 2007 | 1.94 | -12.24% |
| 2006 | 2.21 | +11.06% |
| 2005 | 1.99 | -13.28% |
| 2004 | 2.29 | -23.89% |
| 2003 | 3.01 | +15.57% |
| 2002 | 2.61 | -23.29% |
| 2001 | 3.40 | -13.37% |
| 2000 | 3.92 | +41.80% |
| 1999 | 2.77 | N/A |
Comparison Pfizer (PFE) P/S with competitors
Pfizer (PFE) P/S is 2.22.
| Ticker | Name | P/S | Upside |
|---|---|---|---|
| OGN | Organon & Company | 0.57 | -74.15% |
| NVO | Novo Nordisk | 0.66 | -70.24% |
| GRFS | Grifols SA | 0.67 | -69.84% |
| AMRN | Amarin Corp | 1.39 | -37.52% |
| SCLX | Scilex Holding Company | 1.92 | -13.92% |
| SNY | Sanofi | 2.18 | -1.87% |
| BMY | Bristol-Myers Squibb Company | 2.40 | +7.84% |
| BIIB | Biogen Inc | 2.93 | +31.71% |
| GSK | GSK Plc | 3.22 | +44.92% |
| MRK | Merck & Co Inc | 4.54 | +103.90% |
| AZN | Astrazeneca plc | 4.58 | +106.10% |
| NVS | Novartis AG | 5.07 | +127.90% |
| AMGN | AMGEN Inc | 5.15 | +131.50% |
| GILD | Gilead Sciences Inc | 5.43 | +144.09% |
| JNJ | Johnson & Johnson | 6.34 | +184.99% |
| ABBV | Abbvie Inc | 7.15 | +221.40% |
| LLY | Lilly(Eli) & Company | 14.28 | +541.91% |